Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis

BACKGROUND: Biologic disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs are used in patients with psoriatic arthritis (PsA), but few studies directly compare their clinical efficacy. In such situations, network meta-analysis (NMA) can inform evidence-based decision-making....

Descripción completa

Detalles Bibliográficos
Autores principales: Ruyssen-Witrand, Adeline, Perry, Richard, Watkins, Clare, Braileanu, George, Kumar, Gayathri, Kiri, Sandeep, Nott, Debby, Liu-Leage, Soyi, Hartz, Susanne, Sapin, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046955/
https://www.ncbi.nlm.nih.gov/pubmed/32094304
http://dx.doi.org/10.1136/rmdopen-2019-001117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046955/
https://www.ncbi.nlm.nih.gov/pubmed/32094304
http://dx.doi.org/10.1136/rmdopen-2019-001117

Ejemplares similares